Cost effectiveness of Adalimumab (HUMIRA®) plus Methotrexate vs. Etanercept (ENBREL) plus methotrexate in moderate to severe rheumatoid arthritis (RA)

被引：0
|
作者：
Davies, AS
Hutton, J
Weisman, MH
Cifaldi, MA
Pang, F
Spencer-Green, GT
机构：
[1] MEDTAP Int Inc, Hlth Econ, London, England
[2] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[3] Abbott Labs, Abbott Pk, IL 60064 USA
[4] Abbott Labs Ltd, Maidenhead, Berks, England
[5] Abbott Labs, Parsippany, NJ USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2005年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：68 / 68
页数：1
相关论文
共 50 条
  • [1] Early treatment of rheumatoid arthritis (RA) with adalimumab (HUMIRA®) plus methotrexate vs. adalimumab alone or methotrexate alone:: The PREMIER study.
    Breedveld, FC
    Kavanaugh, AF
    Cohen, SB
    Pavelka, K
    van Vollenhoven, R
    Perez, JL
    Spencer-Green, GT
    Weisman, MH
    ARTHRITIS AND RHEUMATISM, 2004, 50 (12): : 4096 - 4097
  • [2] Sustained efficacy of adalimumab (HUMIRA™) plus methotrexate in rheumatoid arthritis (RA) patients.
    Schiff, MH
    Weisman, MH
    Furst, DE
    Kavanaugh, A
    Fischkoff, SA
    Spencer-Green, GT
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S314 - S315
  • [3] SUSTAINED EFFICACY OF ADALIMUMAB (HUMIRA®) PLUS METHOTREXATE (MTX) IN RHEUMATOID ARTHRITIS (RA) PATIENTS
    Schiff, M. H.
    Weisman, M.
    Furst, D. E.
    Kavanaugh, A.
    Spencer-Green, G.
    Segurado, O. G.
    RHEUMATOLOGY, 2004, 43 : 40 - 40
  • [4] Cost effectiveness of adalimumab (HUMIRA™, Abbott) in the treatment of patients with moderate to severe rheumatoid arthritis (RA)
    Bansback, NJ
    Brennan, A
    Sengupta, N
    Chang, KY
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S215 - S215
  • [5] The Effect of Dose Escalation on the Cost-Effectiveness of Etanercept and Adalimumab with Methotrexate Among Patients with Moderate to Severe Rheumatoid Arthritis
    Incerti, Devin
    Hernandez, Ervant J. Maksabedian
    Tkacz, Joseph
    Jansen, Jeroen P.
    Collier, David
    Gharaibeh, Mahdi
    Moore-Schiltz, Laura
    Stolshek, Bradley S.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2020, 26 (10): : 1236 - 1242
  • [6] ETANERCEPT PLUS METHOTREXATE COMBINATION THERAPY IS EFFICACIOUS IN MODERATE AS WELL AS SEVERE EARLY RHEUMATOID ARTHRITIS
    Nash, Peter
    Breedveld, F. C.
    Robertson, Deborah
    Foehl, Joanne
    Ferdousi, Tahmina
    Freundlich, Bruce
    Koenig, Andrew
    RHEUMATOLOGY, 2011, 50 : ii3 - ii3
  • [7] Patients with early Rheumatoid Arthritis (RA) achieved improved physical function and experienced less fatigue with adalimumab (HUMIRA®) plus Methotrexate (MTX) vs. MTX monotherapy
    Weisman, M. H.
    Breedveld, F. C.
    Cifaldi, M. A.
    Sterz, R.
    Dietz, B. M.
    Spencer-Green, G. T.
    RHEUMATOLOGY, 2006, 45 : I43 - I43
  • [8] The efficacy and safety of Adalimunab (Humira®) plus Methotrexate vs. Adalimumab alone or methotrexate alone in the early treatment of rheumatoid arthritis (RA):: 1-and 2-year results of the premier study
    Breedveld, FC
    Weisman, MH
    Kavanaugh, AF
    Cohen, SB
    Pavelka, K
    Van Vollenhoven, R
    Perez, JL
    Spencer-Green, GT
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 60 - 60
  • [9] Enbrel plus methotrexate induces a superior major clinical response in patients with rheumatoid arthritis vs. methotrexate or enbrel alone: Persistence of the ACR 70 response
    Fleischmann, RM
    Van der Heijde, D
    Klareskog, L
    Keystone, EC
    Peloso, PM
    Bathon, J
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 465 - 465
  • [10] Treating Rheumatoid Arthritis to Target: Outcomes and Predictors in Early Rheumatoid Arthritis Patients Treated with Adalimumab Plus Methotrexate, Methotrexate Alone, or Methotrexate Plus Subsequent Adalimumab
    Smolen, Josef
    Fleischmann, Roy M.
    Emery, Paul
    van Vollenhoven, Ronald F.
    Guerette, Benoit
    Santra, Sourav
    Kupper, Hartmut
    Redden, Laura
    Wolfe, Benjamin
    Kavanaugh, Arthur
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S665 - S665
12345